PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 78 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,062,019 | +40.6% | 59,537 | +17.5% | 0.00% | – |
| Q1 2024 | $1,466,347 | +41.2% | 50,686 | +11.9% | 0.00% | – |
| Q4 2023 | $1,038,479 | +39.1% | 45,289 | +1.2% | 0.00% | – |
| Q3 2023 | $746,681 | -39.2% | 44,765 | +0.6% | 0.00% | – |
| Q2 2023 | $1,229,089 | +179.3% | 44,500 | +132.5% | 0.00% | – |
| Q1 2023 | $440,128 | +180.0% | 19,136 | +32.8% | 0.00% | – |
| Q4 2022 | $157,191 | +40.3% | 14,408 | +8.4% | 0.00% | – |
| Q3 2022 | $112,000 | -21.7% | 13,290 | -26.7% | 0.00% | – |
| Q2 2022 | $143,000 | -72.0% | 18,126 | -16.1% | 0.00% | – |
| Q1 2022 | $511,000 | -29.7% | 21,594 | +1.6% | 0.00% | – |
| Q4 2021 | $727,000 | +99.2% | 21,264 | +3.1% | 0.00% | – |
| Q3 2021 | $365,000 | -35.2% | 20,632 | +64.3% | 0.00% | – |
| Q2 2021 | $563,000 | +106.2% | 12,561 | +19.1% | 0.00% | – |
| Q1 2021 | $273,000 | +31.2% | 10,545 | +2.3% | 0.00% | – |
| Q4 2020 | $208,000 | +193.0% | 10,312 | +185.2% | 0.00% | – |
| Q3 2020 | $71,000 | +7.6% | 3,616 | -2.8% | 0.00% | – |
| Q2 2020 | $66,000 | +247.4% | 3,722 | +38.4% | 0.00% | – |
| Q1 2020 | $19,000 | -24.0% | 2,689 | -23.4% | 0.00% | – |
| Q4 2019 | $25,000 | -32.4% | 3,511 | +13.8% | 0.00% | – |
| Q3 2019 | $37,000 | +19.4% | 3,085 | +21.9% | 0.00% | – |
| Q2 2019 | $31,000 | +63.2% | 2,530 | +14.7% | 0.00% | – |
| Q1 2018 | $19,000 | -58.7% | 2,205 | 0.0% | 0.00% | – |
| Q4 2017 | $46,000 | +53.3% | 2,205 | +28.3% | 0.00% | – |
| Q3 2017 | $30,000 | +150.0% | 1,718 | +67.3% | 0.00% | – |
| Q2 2017 | $12,000 | -7.7% | 1,027 | 0.0% | 0.00% | – |
| Q1 2017 | $13,000 | -56.7% | 1,027 | -23.5% | 0.00% | – |
| Q4 2016 | $30,000 | – | 1,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,449,183 | $43,253,000 | 8.50% |
| BVF INC/IL | 2,367,288 | $41,806,000 | 2.58% |
| RTW INVESTMENTS, LP | 3,383,208 | $59,747,000 | 1.68% |
| Novo Holdings A/S | 824,169 | $14,555,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,013,495 | $17,898,000 | 0.52% |
| Sofinnova Investments, Inc. | 326,064 | $5,758,000 | 0.36% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $44,150,000 | 0.35% |
| Virtus ETF Advisers LLC | 21,639 | $382,000 | 0.18% |
| Baker Brothers Advisors | 1,911,446 | $33,756,000 | 0.15% |
| King Wealth Management Group | 22,000 | $389,000 | 0.11% |